Overview Financials News + Filings Key Docs Ownership
|
|
RedHill Biopharma Ltd. (RDHL)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-21 | Mar-31-20 | Sep-30-19 | Mar-31-19 | Sep-30-18 | Mar-31-18 | Mar-31-17 |
| | 6-K | 6-K | 6-K | 6-K | 6-K | 6-K | 6-K |
| Revenues |
| Commercial Operations U.S. dollars in thousands | 1.1 | | 1.4 | 1.7 | 2.2 | 2.4 | |
| |
| Adjusted EBITDA |
| |
| EBIT |
| Commercial Operations U.S. dollars in thousands | 17.0 | | 9.8 | 9.2 | 9.7 | 10.0 | 0.3 |
| |
| Mix |
| Commercial Operations U.S. dollars in thousands | 5.1% | | 100.0% | 100.0% | 100.0% | 100.0% | |
| |
| Growth |
| Commercial Operations U.S. dollars in thousands | | | -36.5% | -29.0% | | | |
|